[Development of methods of ultra-fine size reduction of slightly soluble medicinal crystals (2). Factors affecting the ultra-fine size reduction of oxolinic acid crystals].
D003460:Crystallization; D006851:Hydrochloric Acid; D010093:Oxolinic Acid; D010316:Particle Size; D011108:Polymers; D013501:Surface-Active Agents; D013678:Technology, Pharmaceutical; D013696:Temperature
D011108:Polymers; D013501:Surface-Active Agents; D010093:Oxolinic Acid; D006851:Hydrochloric Acid